𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Seasonality of births and childhood inflammatory bowel disease

✍ Scribed by Miroslav Mikulecký; Iveta Čierna

Publisher
Springer Vienna
Year
2005
Tongue
English
Weight
73 KB
Volume
117
Category
Article
ISSN
0043-5325

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Genetics of childhood-onset inflammatory
Genetics of childhood-onset inflammatory bowel disease
✍ Paul Henderson; Johan E. van Limbergen; David C. Wilson; Jack Satsangi; Richard 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 908 KB

Nearly a third of inflammatory bowel disease (IBD) patients present in childhood or adolescence, with epidemiological and natural history studies clearly demonstrating a rising incidence in this population. Although early-onset disease has a distinct phenotype, such as more extensive disease at onse

Seasonal variation of enteric infections
Seasonal variation of enteric infections and inflammatory bowel disease
✍ Amnon Sonnenberg 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

## Background: The time trends of inflammatory bowel disease are characterized by short-term variations that affect crohn's disease and ulcerative colitis alike. the aim of the present study was to test whether these variations might be related to exacerbations of inflammatory bowel disease seconda

Date of birth in the occurrence of infla
Date of birth in the occurrence of inflammatory bowel disease
✍ Amnon Sonnenberg 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 523 KB

Background: It has been speculated that prenatal or perinatal exposure to infections affects the risk for developing inflammatory bowel disease (IBD). The aims of the study were to investigate the seasonal and monthly variations of birth dates among patients with Crohn's disease (CD) and ulcerative

Short-term response to adalimumab in chi
Short-term response to adalimumab in childhood inflammatory bowel disease
✍ Joshua D. Noe; Marian Pfefferkorn 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB 👁 2 views

## Background: Adalimumab is effective for adults with moderate to severe crohn's disease (cd). data in children with inflammatory bowel disease (ibd) is sparse. we aim to evaluate pediatric ibd response to adalimumab. ## Methods: We conducted a retrospective chart review of pediatric ibd patient